Wang Jian, Xu Chuyi, Zheng Qiuyu, Yang Kai, Lai Ning, Wang Tao, Tang Haiyang, Lu Wenju
State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510180, China.
Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona, Tucson, AZ 85721-0202, USA.
Cell Death Discov. 2017 Nov 27;3:17074. doi: 10.1038/cddiscovery.2017.74. eCollection 2017.
Previous studies have demonstrated that besides the classic canonical transient receptor potential channel family, Orai family and stromal interaction molecule 1 (STIM1) might also be involved in the regulation of store-operated calcium channels (SOCCs). An increase in cytosolic free Ca concentration promoted by store-operated Ca entry (SOCE) in pulmonary arterial smooth muscle cells (PASMCs) is a major trigger for pulmonary vasoconstriction and proliferation and migration of PASMCs. In this study, our data revealed the following: (1) in both rat distal pulmonary arteries and PASMCs, chronic hypoxia exposure upregulated the expression of Orai1 and Orai2, without affecting Orai3 and STIM1; (2) either heterozygous knockout of HIF-1 in mice or knockdown of HIF-1 in PASMCs abolished the hypoxic upregulation of Orai2, but not Orai1, suggesting the hypoxic upregulation of Orai2 depends on HIF-1; and (3) using small interference RNA knockdown strategies, Orai1, 2, 3 and STIM1 were all shown to mediate SOCE in hypoxic PASMCs. Together, these results suggested that the components of SOCCs, including Orai1, 2, 3 and STIM1, may lead to novel therapeutic targets for the treatment of chronic hypoxia-induced pulmonary hypertension.
以往的研究表明,除了经典的瞬时受体电位通道家族外,Orai家族和基质相互作用分子1(STIM1)也可能参与了钙库操纵性钙通道(SOCCs)的调节。肺动脉平滑肌细胞(PASMCs)中钙库操纵性钙内流(SOCE)所促进的胞质游离钙浓度升高,是肺动脉收缩以及PASMCs增殖和迁移的主要触发因素。在本研究中,我们的数据揭示了以下几点:(1)在大鼠远端肺动脉和PASMCs中,慢性低氧暴露上调了Orai1和Orai2的表达,而不影响Orai3和STIM1;(2)小鼠中HIF-1的杂合敲除或PASMCs中HIF-1的敲低消除了Orai2的低氧上调,但未消除Orai1的低氧上调,这表明Orai2的低氧上调依赖于HIF-1;(3)使用小干扰RNA敲低策略显示,Orai1、2、3和STIM1均介导低氧PASMCs中的SOCE。总之,这些结果表明,包括Orai1、2、3和STIM1在内的SOCCs成分可能成为治疗慢性低氧诱导的肺动脉高压的新治疗靶点。